$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Josh Brown: Biotech growth stocks immune to disruption risk
12:37pm, Wednesday, 11'th Mar 2026
Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC's Halftime Report this week about large-cap biotech: “These are growth stocks where you don't have to worry about disrupti
Goldman Sachs Large Cap Equity Fund Q4 2025 Portfolio Activity
09:36am, Wednesday, 11'th Mar 2026
Our position in American pharmaceutical company, Eli Lilly & Company (1.8%), was a top contributor to relative returns during the fourth quarter. Our position in global semiconductor company, Advanced
Eli Lilly to invest $3 billion in China over next decade
05:13am, Wednesday, 11'th Mar 2026
Eli Lilly plans to invest $3 billion over the next decade to expand supply chain capacity in China and build production capacity for type-2 diabetes and obesity treatment orforgli
Bank of Montreal Can Buys 127,679 Shares of Eli Lilly and Company $LLY
05:42am, Tuesday, 10'th Mar 2026
Bank of Montreal Can boosted its position in Eli Lilly and Company (NYSE: LLY) by 8.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The
Eli Lilly (LLY) Laps the Stock Market: Here's Why
06:46pm, Monday, 09'th Mar 2026
In the closing of the recent trading day, Eli Lilly (LLY) stood at $1, denoting a +1.82% move from the preceding trading day.
Virtus Large Cap Growth SMA Q4 2025 Portfolio Review
03:21pm, Monday, 09'th Mar 2026
The Silvant Large Cap Growth SMA returned +2.69% (gross)/+1.94% (net) for the quarter, outperforming the Russell 1000 Growth Index's return of +1.12%. Eli Lilly and Alphabet were among the top stock c
Should You Buy Eli Lilly Stock Now or Wait for More of a Pullback?
02:00pm, Monday, 09'th Mar 2026
Eli Lilly stock is down 13% from its 52-week high. Analysts still see some decent upside for the stock, with its average price target being north of $1,200.
2 Top AI Healthcare Stocks to Buy and Hold
11:00am, Monday, 09'th Mar 2026
Pfizer and Eli Lilly are both actively using artificial intelligence to improve their businesses. While these efforts are noteworthy, there are still better reasons to invest in the two stocks.
Eli Lilly says some Medicare plans may exceed $50 cap for weight-loss drugs
10:52am, Monday, 09'th Mar 2026
Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap on out-of-pocket costs for its weight-loss drugs, under the Medicare agency's weight-los
Market Today: Jobs Slide, Oil Soars, Media M&A and Major Recalls
05:36pm, Friday, 06'th Mar 2026
Guru Stock PicksRon Baron has made the following transactions:Reduce in ACGL by 4.12%Add in CHH by 39.44%Stock News U.S. payrolls contract: The U.S. added -92,0
Lilly (LLY) Down 3.7% Since Last Earnings Report: Can It Rebound?
12:31pm, Friday, 06'th Mar 2026
Lilly (LLY) reported earnings 30 days ago. What's next for the stock?
Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies
06:05am, Friday, 06'th Mar 2026
U.S. considers global AI chip export restrictions, impacting Nvidia and AMD as shares fall on regulatory risk. A 30-day U.S. waiver allows India to purchase stranded Russian crude, aiming to stabilize
Elfun Trusts Exits Texas Instruments Inc, Impacting Portfolio by -1.57%
04:00pm, Thursday, 05'th Mar 2026
Exploring the Strategic Moves in Elfun Trusts (Trades, Portfolio)' Fourth Quarter 2025 N-PORT Filing Elfun Trusts (Trades, Portfolio) recently submitted its N-
What Are The Biggest Risks To Eli Lilly Stock?
10:25am, Thursday, 05'th Mar 2026
Eli Lilly stock (LLY) is currently trading near $1,000, reflecting a decline of over 11% from its 52-week high as investors recalibrate expectations against emerging headwinds.
Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear?
09:16am, Thursday, 05'th Mar 2026
LLY's shares fall 5% in a month amid pricing fears and obesity-drug rivalry, but booming Mounjaro and Zepbound sales and a deep pipeline keep growth hopes alive.
Sign In
Buy LLY